Healthy Habits Extended Dementia-Free Years in Study

Researchers found that avoiding midlife smoking, diabetes, and high blood pressure significantly delayed dementia onset.

Updated on Sept. 21, 2026 in Alzheimer’s

Flat opaque gouache-painted illustration of delicate, intertwined neural fibers and root-like vascular systems, evoking long-term brain health and cognitive preservation. — A study of over 12,000 individuals suggests that managing vascular health—specifically avoiding smoking, diabetes, and hypertension—can add over a decade of dementia-free life. AI Illustration. Upload story photo >

Live Poll

Do you believe lifestyle changes can significantly lower your personal risk of developing dementia?

A study of over 12,000 individuals tracked since middle age found that those free of diabetes, high blood pressure, and smoking lived nearly 13 years longer without dementia. These findings highlight how vascular health impacts long-term cognitive function.

Why it matters

High blood pressure, diabetes, and smoking damage brain blood vessels and trigger inflammation, which are key drivers of cognitive decline. Managing these conditions in middle age serves as a critical strategy for preserving brain health.

Participants without high blood pressure, diabetes, or smoking history lived nearly 13 years longer without dementia than those with these conditions. Adults showing high p-tau217 levels face a 38% risk of cognitive impairment within five years.

The players

Food and Drug Administration

The agency is the federal regulatory body responsible for clearing medical devices and diagnostic tests for clinical use in the United States.

The details

The FDA has cleared four blood tests that measure p-tau217 protein levels to identify amyloid buildup in symptomatic patients. These tests are currently categorized as risk indicators rather than absolute clinical guarantees of Alzheimer's disease.

Participants were tracked over several decades starting at an average age of 56.
A study finding regarding healthy habits was reported last year.
High p-tau217 levels indicate a 38% risk of impairment within five years.
A higher risk of impairment is observed over a window of more than 10 years.

The Big Picture

This research follows the clinical validation of amyloid-targeting Alzheimer's therapies by emphasizing how early life intervention and biomarker tracking can alter the course of cognitive health.

Patients may now access FDA-cleared blood tests to measure p-tau217 levels if they are already exhibiting cognitive symptoms. These tests provide quantifiable risk data that can inform lifestyle adjustments and future treatment discussions with a physician.

The takeaway

Maintaining vascular health in middle age is a powerful tool for extending cognitive longevity. Individuals concerned about cognitive health should prioritize screenings for hypertension and diabetes to mitigate long-term brain inflammation.